AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease

Grant

Date/time Interval

  • April 9, 2018 - August 31, 2022
  • Total Award Amount

  • 4193867.00
  • Direct Costs

  • 3404512.00
  • Sponsor Award Id

  • UH3TR002450
  • Contributor

  • ace1049   Investigator  
  • caban   Investigator  
  • cutterg   Investigator  
  • jmwells   Investigator  
  • sboddulu   Investigator  
  • mdrans99   Principal Investigator